title: Can the battle against tuberculosis gain from epigenetic research?
abstract: A healthy immune system needs to be highly plastic to cope with host defense and surveillance. What mechanisms provide this plasticity? Considering the threat of infectious diseases to a large part of the world's population, can these mechanisms possibly be of use in the ongoing battle against infectious diseases? Against the backdrop of the pandemic nature of tuberculosis, we discuss whether and how epigenetic mechanisms can shed light on our understanding of infectious disease, and if epigenetic marks can be employed to monitor latent infection, disease reactivation or treatment response.
authors.affiliation: Department of Immunology, Max Planck Institute for Infectious Biology, Charitéplatz 1, D-10117 Berlin, Germany.
authors.forename: Maria M
authors.initials: MM
authors.lastname: Esterhuyse
authors.forename: Heinz G
authors.initials: HG
authors.lastname: Linhart
authors.forename: Stefan H E
authors.initials: SH
authors.lastname: Kaufmann
mesh_terms: D000818:Animals; D035843:Biomedical Research; D057890:Epigenomics; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000235:genetics / Q000502:physiology; D014376:Tuberculosis / Q000235:genetics* / Q000276:immunology* / Q000382:microbiology*